NCT07418918

Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)

A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study on the Efficacy and Safety of Lactobacillus Bicomponent Viable Capsules for Vaginal Use in the Treatment of Bacterial Vaginosis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, randomized, double-blind, placebo-controlled phase IIb clinical study, to evaluate the efficacy and safety of the dual - live Lactobacilli-containing vaginal capsule for the treatment of bacterial vaginosis.

Conditions

• Bacterial Vaginosis

Interventions

Type	Name	Description
DRUG	Vaginal Lactobacillus Dual Probiotic Capsules	Vaginal Lactobacillus Dual Probiotic Capsules, at the prescribed dose and course of treatment, for regulating vaginal microecology.
DRUG	Placebo	Placebo capsule with the same appearance as the study drug, at the same dose and course of treatment as the experimental group.

Timeline

• Start date: 2023-01-03
• Primary completion: 2023-09-01
• Completion: 2023-11-11
• First posted: 2026-02-18
• Last updated: 2026-02-18

Locations

1 site across 1 country: China